Abstract
On November 19, 1987, the Canadian Senate gave final approval to a number of far-reaching and controversial amendments to the Canadian Patent Act ("Amending Act"). On the same day, following Senate approval, the Bill C-22 became law upon royal assent. The Patent Act, enacted in 1935, had remained largely unchanged, notwithstanding amendments in 1952 and 1969. The present amendments therefore constitute an unprecedented overhaul of the Candian law of patents.
Recommended Citation
Milan Chromecek,
The Amended Canadian Patent Act: General Amendments and Pharmaceutical Patents Compulsory Licensing Provisions,
11 Fordham Int'l L.J. 504
(1987).
Available at: https://ir.lawnet.fordham.edu/ilj/vol11/iss3/2
